18 Aug 2017 | 11:57 PM
 

Syncom Formulation (India) Ltd. Share Price Live (BSE)
0

BSE Code: 524470 | NSE Symbol:
1.44
-0.03
(-2.04 %)
18 Aug 2017 | 03:41 PM
Change company
  • Open (Rs)
    1.47
  • Prev. close (Rs.)
    1.47
  • High (Rs.)
    1.49
  • Low (Rs.)
    1.43
  • 52W H (Rs.)
    2.95
  • 52W L (Rs.)
    1.40
  • Volume (Rs.)
    676753
  • MCap (Rs in Cr.)
    112.42
  • Open (Rs)
  • High (Rs)
  • Low (Rs)
  • Prev. close(Rs)
  • Contracts Tra.
  • Turnover (Cr.)
  • Open Interest
  • Open Int. chg
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
0.13
Operating Margin (%)
9.02
Gross Profit Margin (%)
7.39
Net Profit Margin (%)
5.63
Total Debt/Equity
0.05
Dividend payout Ratio (Net Profit)
18.14
Earning Retention Ratio
82.04

News

16 Aug 2017 - 11:14:00-The company reported standalone net profit of Rs 2...
16 Mar 2016 - 10:55:00-Syncom Formulations (India) engaged in the business of pharmaceutical formulations said that it has ...

Announcements

18-Aug-2017
Syncom Formul. - Fixes Book Closure for Dividend & AGM
01-Aug-2017
Syncom Formul. - Board Meeting On Monday 14Th August2017 AT 3:30 P.M.
01-Aug-2017
Syncom Formul. - Closure of Trading Window
12-Jul-2017
Syncom Formul. - Financial Results For 31.03.2017 (Revised Declaration)
11-Jul-2017
Syncom Formul. - Shareholding for the Period Ended June 30 2017

Religare Research

18 Aug 2017 | 06:05 PM
Nifty recovered marginally in the passing week and gained over a percent. Sentiment was upbeat for m...
18 Aug 2017 | 04:47 PM
This week, we haven’t initiated fresh position, citing excessive volatility and possibility of furth...
18 Aug 2017 | 01:56 PM
Srikalahasthi Pipes Ltd (SPL) reported in-line numbers on the profit front with 14.7% & 15.2% YoY de...
18 Aug 2017 | 09:52 AM
The Indian rupee recouped most of its losses to end little changed against the dollar in thin tradin...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
No Data Available

Shareholding Pattern

      
Promotors38.98%
Mutual Funds/UTI0.00%
FI/Banks0.00%
Insurance0.00%
FII0.00%
Government0.00%
Others9.21%

Peer Group

Company Intraday Graph
 Neuland Laboratories Ltd.
1,269.65(-2.26)
3578
 Kovai Medical Center and Hospital Ltd.
1,230.00(-3.46)
11816
 Merck Ltd.
1,143.25(1.24)
3302
 Coral Laboratories Ltd.
990.00(-0.98)
3462

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Syncom Formulation (India) Ltd.-0.08-0.31-0.59
NIFTY(S&P CNX)10.25311.651,015.70
BSE SENSEX-550.10865.913,055.93
BSE 50013.92325.431,527.73

Corporate Details

Key Personal
Kedarmal Bankda
Exe.Chairman & W T D
Rinki Ankit Bankda
Woman Director
Vijay Shankarlal Bankda
Managing Director
Key Address
Registered Office
7 Niraj Industrial Estate Off Mahakali Caves Road Andheri (East),Mumbai,Maharashtra

Tel:022-30887744 30887754 30887756, Fax:022-30887755

info@sfil.in
http://www.sfil.in
Registrar Office
Ankit Consultancy Pvt. Ltd.
Add. :Plot No. 60 Electronic Complex Pardeshipura

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Syncom Formulation (India) Ltd. that will help you decide whether to buy, sell or hold Syncom Formulation (India) Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Syncom Formulation (India) Ltd.